Toll Free 1-866-9-STATRX | Contact Us
Transgender hormone therapy (THT) involves the taking of estrogen or testosterone hormones to induce a gender reassignment. THT allows a psychological transition from one gender to another (female to male, or male to female), and an anatomical transition from one sex to another (woman to man, or man to woman).
THT is typically prescribed for individuals undergoing gender-identity disorders, or when a provider and patient mutually agree upon a request for gender reassignment. In the U.S., patients can be eligible for THT if they are: 18 years of age or older, can demonstrate knowledge of what hormones can and cannot medically do (including benefits and risks), and have at least three (3) months experience living in their desired gender or have seen a mental health professional for at least three (3) months of psychotherapy.
Mainly targeting the endocrine system, hormone therapy promotes the control of sex and gender characteristics such as: the development of breasts, facial hair, and reproductive systems. Typically, transgender hormones allow individuals going through the transgender process to feel more comfortable with their bodies and with themselves, but it can take many years before a person considers the transition satisfactory.
THT is a process that requires medical advisory. Numerous risks are involved with THT, which include deepvein thrombosis (DVT), pulmonary embolisms, benign pituitary tumors, gallbladder disease, hypertension, hypothyroidism, liver disease, frequent migraines, weight gain, and worsening of depression. The risks of transgender hormone therapy increase if patients are overweight, over the age of 40 years old, or are smokers.
Stat RX Pharmacy professionals are trained in providing specialty medications and hormone therapies such as THT. Our expert clinicians are here to provide comprehensive care as patients undergo treatment regimens such as THT, ensuring that therapy is as consistent and efficient as possible. Contact us today to speak with a pharmacist about THT.
